132 related articles for article (PubMed ID: 11118857)
61. Early detection, reactivation of cytomegalovirus DNA & immediate early (IE)-mRNA expression in hematopoietic stem cell-transplant patients.
Thomas S; Duraisamy SK; Ahmed R; Abraham A; Vishwabandhya A; Mathews V; Srivastava A; Samuel P; Kannangai R; Abraham OC; George B; Abraham AM
Indian J Med Microbiol; 2024; 47():100521. PubMed ID: 38072066
[TBL] [Abstract][Full Text] [Related]
62. Identification of active cytomegalovirus infection by analysis of immediate-early, early and late transcripts in peripheral blood cells of immunodeficient patients.
Meyer T; Reischl U; Wolf H; Schüller C; Arndt R
Mol Cell Probes; 1994 Aug; 8(4):261-71. PubMed ID: 7870068
[TBL] [Abstract][Full Text] [Related]
63. Monitoring human cytomegalovirus infection in pediatric hematopoietic stem cell transplant recipients: using an affordable in-house qPCR assay for management of HCMV infection under limited resources.
Khansarinejad B; Soleimanjahi H; Mirab Samiee S; Hamidieh AA; Paryan M; Sanahmadi Y; Karami M; Mondanizadeh M
Transpl Int; 2015 May; 28(5):594-603. PubMed ID: 25703481
[TBL] [Abstract][Full Text] [Related]
64. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
Solano C; Muñoz I; Gutiérrez A; Farga A; Prósper F; García-Conde J; Navarro D; Gimeno C
J Clin Microbiol; 2001 Nov; 39(11):3938-41. PubMed ID: 11682510
[TBL] [Abstract][Full Text] [Related]
65. Management of human cytomegalovirus infection in transplantation: validation of virologic cut-offs for preemptive therapy and immunological cut-offs for protection.
Gerna G; Lilleri D; Furione M; Baldanti F
New Microbiol; 2011 Jul; 34(3):229-54. PubMed ID: 21811744
[TBL] [Abstract][Full Text] [Related]
66. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients.
Piiparinen H; Höckerstedt K; Grönhagen-Riska C; Lautenschlager I
J Clin Virol; 2004 Jul; 30(3):258-66. PubMed ID: 15135746
[TBL] [Abstract][Full Text] [Related]
67. Human cytomegalovirus immediate early and late transcripts in peripheral blood leukocytes: diagnostic value in renal transplant recipients.
Meyer-König U; Serr A; von Laer D; Kirste G; Wolff C; Haller O; Neumann-Haefelin D; Hufert FT
J Infect Dis; 1995 Mar; 171(3):705-9. PubMed ID: 7876623
[TBL] [Abstract][Full Text] [Related]
68. Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients.
Gerna G; Furione M; Baldanti F; Percivalle E; Comoli P; Locatelli F
Br J Haematol; 1995 Nov; 91(3):674-83. PubMed ID: 8555075
[TBL] [Abstract][Full Text] [Related]
69. Human cytomegalovirus end-organ disease is associated with high or low systemic viral load in preemptively treated solid-organ transplant recipients.
Gerna G; Lilleri D; Furione M; Castiglioni B; Meloni F; Rampino T; Agozzino M; Arbustini E
New Microbiol; 2012 Jul; 35(3):279-87. PubMed ID: 22842597
[TBL] [Abstract][Full Text] [Related]
70. Quantitation of the spliced late gene of human cytomegalovirus and its kinetics during experimental infection.
Hänfler J; Kreuzer KA; Laurisch K; Tomic S; Oettle H; Schmidt CA
Med Microbiol Immunol; 2002 Mar; 190(4):161-5. PubMed ID: 12005328
[TBL] [Abstract][Full Text] [Related]
71. Quantitative competitive NASBA for measuring mRNA expression levels of the immediate early 1, late pp67, and immune evasion genes US3, US6 and US11 in cells infected with human cytomegalovirus.
Greijer AE; Adriaanse HM; Kahl M; Tacken NM; Oldenburg N; Sijlmans A; van de Crommert JM; Dekkers CA; Sillekens PT; Middeldorp JM
J Virol Methods; 2001 Aug; 96(2):133-47. PubMed ID: 11445144
[TBL] [Abstract][Full Text] [Related]
72. Rising levels of human cytomegalovirus (HCMV) antigenemia during initial antiviral treatment of solid-organ transplant recipients with primary HCMV infection.
Gerna G; Zavattoni M; Percivalle E; Grossi P; Torsellini M; Revello MG
J Clin Microbiol; 1998 Apr; 36(4):1113-6. PubMed ID: 9542949
[TBL] [Abstract][Full Text] [Related]
73. Monitoring of human cytomegalovirus infection in bone marrow and liver transplant recipients by antigenaemia assay and enzyme-linked immunosorbent assay.
Zhang X; Fan J; Yang MF; Chen XM; Gao HN; Zhao H; Ma WH; Li LJ
J Int Med Res; 2009; 37(1):31-6. PubMed ID: 19215671
[TBL] [Abstract][Full Text] [Related]
74. The impact of early cytomegalovirus infection and disease in renal transplant recipients.
Sagedal S; Hartmann A; Rollag H
Clin Microbiol Infect; 2005 Jul; 11(7):518-30. PubMed ID: 15966969
[TBL] [Abstract][Full Text] [Related]
75. Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients.
Gerna G; Lilleri D; Caldera D; Furione M; Zenone Bragotti L; Alessandrino EP
Bone Marrow Transplant; 2008 May; 41(10):873-9. PubMed ID: 18209721
[TBL] [Abstract][Full Text] [Related]
76. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.
Hernando S; Folgueira L; Lumbreras C; San Juan R; Maldonado S; Prieto C; Babiano MJ; Delgado J; Andres A; Moreno E; Aguado JM; Otero JR
Transplant Proc; 2005 Nov; 37(9):4094-6. PubMed ID: 16386635
[TBL] [Abstract][Full Text] [Related]
77. Diagnosis and monitoring of acute cytomegalovirus infection in peripheral blood of transplant recipients by nested reverse transcriptase polymerase chain reaction (RT-PCR).
Lassner D; Geissler F; Bosse S; Hofmann J; Witzigmann H; Remke H; Hauss J; Wagner O
Transpl Int; 2000; 13 Suppl 1():S366-71. PubMed ID: 11112034
[TBL] [Abstract][Full Text] [Related]
78. Monitoring for cytomegalovirus infection in organ transplant recipients: analysis of pp65 antigen, DNA and late mRNA in peripheral blood leukocytes.
Gaeta A; Nazzari C; Angeletti S; Lazzarini M; Mazzei E; Mancini C
J Med Virol; 1997 Nov; 53(3):189-95. PubMed ID: 9365881
[TBL] [Abstract][Full Text] [Related]
79. Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection.
Chiereghin A; Potena L; Borgese L; Gibertoni D; Squarzoni D; Turello G; Petrisli E; Piccirilli G; Gabrielli L; Grigioni F; Lazzarotto T
J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29305542
[TBL] [Abstract][Full Text] [Related]
80. Longitudinal monitoring of latent and active human cytomegalovirus infections in peripheral blood of heart transplant recipients by single-tube nested RT-PCR.
Wolff D; Skourtopoulos M; Hörnschemeyer D; Wolff C; Körner M; Körfer R; Kleesiek K
Microbiol Res; 1996 Dec; 151(4):343-9. PubMed ID: 9022299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
